Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,850.00    155.00 (2.32%)
Bid:
6,850.00
Ask:
6,855.00
Spread: 5.00 (0.073%)
Market Cap: £5.06b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 Nov 2009 07:00

RNS Number : 1535C
Spirax-Sarco Engineering PLC
09 November 2009
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Monday 9th November 2009

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the period since 1st July 2009.

Trading

Since the half year, the pace of decline in our sales has stabilised. Sales for the year to date through October were down 9% in constant currency against strong results last year. Exchange rates have continued to be favourable and have added 10% to Group revenues in 2009 compared with average exchange rates in calendar year 2008.

Trading margin this year has benefited from exchange rates and, since the end of the half year, has benefited from lower materials costs and reduced operating costs. We have completed the announced headcount reductions which, together with further attrition, means our headcount is now 7% lower than the start of the year. The reductions are largely in manufacturing and administrative support, with cost benefits in the second half year and continuing to be delivered in 2010.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 31st October 2009 of £1m despite funding the acquisition of MasoSine in August for £22m and Intervalf in October for £3m. There has been no material change in the financial position of the Group during the period. Capital investment is well above the level in recent years as we continue to invest in projects with good returns to deliver more efficient manufacturing processes and capacity expansion, particularly in developing markets.

Outlook

Our strong cash position has enabled us to continue to make investments in developing new products, expanding our market penetration and improving operating efficiency, even through this difficult period. The Group's strong customer value proposition and diversity of end user markets, customers, products and geographic spread, give us confidence in our future prospects.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBXUGGGCL
Date   Source Headline
22nd May 20139:14 amRNSDirector/PDMR Shareholding
9th May 20134:22 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 20139:42 amRNSTotal Voting Rights
1st May 20138:53 amRNSChange of Director Details
18th Apr 20133:51 pmRNSHolding(s) in Company
12th Apr 20138:48 amRNSDirector/PDMR Shareholding
10th Apr 201311:01 amRNSDirector/PDMR Shareholding Replacement
10th Apr 20138:50 amRNSDirector/PDMR Shareholding
2nd Apr 201312:39 pmRNSTotal Voting Rights
22nd Mar 20139:41 amRNSAnnual Financial Report
19th Mar 20133:28 pmRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSDirector/PDMR Shareholding
7th Mar 20137:00 amRNSFinal Results 2012
6th Mar 20132:03 pmRNSTotal Voting Rights
26th Feb 20133:30 pmRNSDirector Declaration
5th Feb 20139:37 amRNSTotal Voting Rights
2nd Jan 20133:54 pmRNS2013 Key Dates
2nd Jan 20133:54 pmRNSTotal Voting Rights
2nd Jan 20133:54 pmRNSDirector/PDMR Shareholding
21st Dec 20125:21 pmRNSDirector/PDMR Shareholding
14th Dec 20129:07 amRNSDirector/PDMR Shareholding
6th Dec 20122:58 pmRNSDirector/PDMR Shareholding
3rd Dec 20124:03 pmRNSTotal Voting Rights
15th Nov 20128:25 amRNSHolding(s) in Company
8th Nov 20123:52 pmRNSHolding(s) in Company
7th Nov 20129:30 amRNSAcquisition
7th Nov 20127:00 amRNSInterim Management Statement
2nd Nov 20122:16 pmRNSTotal Voting Rights
23rd Oct 20123:19 pmRNSHolding(s) in Company
18th Oct 20124:36 pmRNSHolding(s) in Company
12th Oct 20122:38 pmRNSDirector/PDMR Shareholding
11th Oct 201210:51 amRNSDirector/PDMR Shareholding
11th Oct 201210:50 amRNSHolding(s) in Company
1st Oct 201211:30 amRNSTotal Voting Rights
28th Sep 201210:25 amRNSHolding(s) in Company
24th Sep 20122:28 pmRNSHolding(s) in Company
3rd Sep 20123:11 pmRNSTotal Voting Rights
30th Aug 20124:00 pmRNSHolding(s) in Company
22nd Aug 20127:00 amRNSSpirax Sarco Plc Interim Results 2012
1st Aug 201211:21 amRNSTotal Voting Rights
1st Aug 201211:20 amRNSHolding(s) in Company
25th Jul 201210:00 amRNSDates for 2012 Half-Year Results
17th Jul 20123:56 pmRNSHolding(s) in Company
16th Jul 201210:00 amRNSBoard Appointment
5th Jul 201212:05 pmRNSChange of Director Details
3rd Jul 20124:54 pmRNSTotal Voting Rights
1st Jun 201212:35 pmRNSTotal Voting Rights
31st May 20128:27 amRNSHolding(s) in Company
25th May 201210:42 amRNSResult of AGM - Replacement Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.